Trial
NCT00000752
Preventing Frequent Sinus Infections in HIV-Infected Patients
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Adams Laboratories; Glaxo Wellcome
Condition
HIV Infections
Intervention
Pseudoephedrine hydrochloride
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-28